NVCR icon

NovoCure
NVCR

Overview Fund Activity

235 hedge funds and large institutions have $1.59B invested in NovoCure in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 45 closing their positions.

Holders
235
Holders Change
-1
Holders Change %
-0.42%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
47
Increased
75
Reduced
71
Closed
45
Calls
$22.4M
Puts
$5.55M
Net Calls
+$16.8M
Net Calls Change
+$223K

Top Buyers

1
BlackRock
1
BlackRock
New York
$208M
2
Capital International Investors
2
Capital International Investors
California
$200M
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$29.3M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$191M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$40.7M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$13.8M
2
Bank of America
2
Bank of America
North Carolina
$9.45M
3
SCM
3
Soleus Capital Management
Connecticut
$1.87M
4
CSS
4
Cubist Systematic Strategies
Connecticut
$6.06M
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$5.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
BIA
276
Bell Investment Advisors
California
– -$563 -36 Closed
CTC
277
Central Trust Company
Missouri
– -$282 -18 Closed
8 9 10 11
12